Cargando…

Four years stability of type D personality in patients with moderate to severe psoriasis and its implications for psychological impairment()()

BACKGROUND: Psoriasis is a systemic auto-inflammatory disease that is related to an increased risk of organic and psychological comorbidities. Type D is a stable personality trait in healthy subjects but there is no data regarding its stability in patients with moderate-severe psoriasis. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguayo-Carreras, Paula, Ruiz-Carrascosa, José Carlos, Ruiz-Villaverde, Ricardo, Molina-Leyva, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441460/ https://www.ncbi.nlm.nih.gov/pubmed/34274184 http://dx.doi.org/10.1016/j.abd.2021.02.005

Ejemplares similares

Study of the Visceral Adipose Tissue in a Cohort of Patients with Moderate-Severe Psoriasis Treated with Biological Therapy
por: Ricardo, Ruiz-Villaverde, et al.
Publicado: (2022)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
por: Molina-Leyva, Alejandro, et al.
Publicado: (2015)

A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
por: Salgado-Boquete, Laura, et al.
Publicado: (2021)

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
por: Husein-ElAhmed, Husein, et al.
Publicado: (2013)

Sexual Distress in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study
por: Cuenca-Barrales, Carlos, et al.
Publicado: (2019)

Familial Frontal Fibrosing Alopecia: Report of a case and systematic review of the literature
por: Cuenca-Barrales, Carlos, et al.
Publicado: (2021)

Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

PILOT STUDY OF SEXUAL DYSFUNCTION IN PATIENTS WITH PSORIASIS: INFLUENCE OF BIOLOGIC THERAPY
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Case for diagnosis()
por: Leyva, Alejandro Molina, et al.
Publicado: (2014)

Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
por: Belinchon Romero, Isabel, et al.
Publicado: (2023)

Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use
por: Navarro-Triviño, Francisco José, et al.
Publicado: (2021)

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
por: ZOZAYA, Néboa, et al.
Publicado: (2022)

From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
por: Vidal, Silvia, et al.
Publicado: (2021)

Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
por: Belinchón Romero, Isabel, et al.
Publicado: (2021)

Tissue Engineering and Regeneration of the Human Hair Follicle in Androgenetic Alopecia: Literature Review
por: Llamas-Molina, José María, et al.
Publicado: (2022)

Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review
por: Ferrer-Alcala, Maria-Angeles, et al.
Publicado: (2021)

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
por: Maravilla-Herrera, Paulina, et al.
Publicado: (2023)

PSYCHOLOGICAL FACTORS IN PSORIASIS
por: Chaudhury, S., et al.
Publicado: (1998)

Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing
por: Gracia-Cazaña, Tamara, et al.
Publicado: (2023)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Herpes zóster oftálmico en el contexto de la pandemia por COVID-19
por: Ayén-Rodriguez, Angela, et al.
Publicado: (2021)

Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis
por: Dodero-Anillo, Jose Manuel, et al.
Publicado: (2022)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
por: Brunner, P.M., et al.
Publicado: (2021)

Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740
por: Vidal, Silvia, et al.
Publicado: (2022)

Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study
por: SÁNCHEZ-DÍAZ, Manuel, et al.
Publicado: (2023)

Old World Cutaneous Leishmaniasis: Successful response to topical imiquimod
por: Llamas-Molina, Jose M., et al.
Publicado: (2022)

Treatment Approaches to Moderate to Severe Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2017)

Erythema Increase Predicts Psoriasis Improvement after Phototherapy
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2021)

Does Personality Moderate the Effects of Mindfulness Training for Medical and Psychology Students?
por: de Vibe, Michael, et al.
Publicado: (2013)

Four Essential Tremor Cases with Moderately Impaired Gait: How Impaired can Gait be in this Disease?
por: Louis, Elan D., et al.
Publicado: (2013)

Spotlight on Topical Long-Term Management of Plaque Psoriasis
por: Carrascosa, Jose Manuel, et al.
Publicado: (2020)

Moderating Effect of Psychological Resilience on Functional Impairment in Relation to Subsequent Depression
por: Choi, Shinae, et al.
Publicado: (2020)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
por: Adsit, Sandra, et al.
Publicado: (2017)

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis()
por: Mota, Cynthia Cristina Ferreira, et al.
Publicado: (2022)

Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil
por: Lopes, Nilcéia, et al.
Publicado: (2019)

Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
por: Carrascosa, Jose-Manuel, et al.
Publicado: (2018)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
por: Rosés Gibert, Pau, et al.
Publicado: (2022)

Penfigoide ampolloso sobre herida quirúrgica. ¿Una complicación emergente en el anciano?
por: Ródenas-Herranz, Teresa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_blnp7l689fdqcmbeik7ogh5849